Analysis of Visual Acuity and Retinal State in the Eyes with Central Serous Chorioretinopathy
중심장액성맥락망막병증 눈의 시력 및 망막 상태 분석

Jong Kil Choi, Kyung Min Lee, Se-il Kim, So Ra Kim, Mijung Park
2016 Journal of Korean Ophthalmic Optics Society  
································································································································································································································ Purpose: The relationship between retinal conditions such as macular thickness and retinal volume of the eyes with central serous chorioretinopathy(CSC) and visual acuity was investigated. Methods: A total of 136 eyes from 78 subjects was divided into 5 groups: CSC eyes
more » ... roups: CSC eyes under treatment and its asymptomatic contralateral eyes, fully cured CSC eyes after the diagnosis and its contralateral, and normal eyes. Their uncorrected visual acuity(UCVA), best corrected visual acuity(BCVA), retinal thickness and retinal volume were further examined. Results: All of UCVA, BCVA, retinal thickness and retinal volume of CSC eyes under treatment were significantly different from those of asymptomatic contralateral eyes, fully cured CSC eyes and normal eyes. BCVA of the asymptomatic contralateral eyes was not significantly different from it of normal eyes, however, its retinal thickness and volume were significantly different from those of normal eyes. Increased degree of retinal volume along with the increase of retinal volume was greater in CSC eyes and its asymptomatic contralateral eyes, fully cured CSC eyes and its contralateral eyes than normal eyes. Conclusions: From the present study, it was revealed that the retinal thickness and volume of asymptomatic contralateral eyes of CSC increase as well as CSC eyes, and the change of BCVA due to CSC occurs only when the retinal thickness and volume increase in some extent. ································································································································································································································ 서 론 대표적인 망막질환의 하나로 1866년 Von Graefe [1] 가 중 심성 재발 망막염을 처음 기술한 이래, 1967년 Gass [2] 가 중심장액성맥락망막병증이란 용어를 처음 사용하였다. 맥 락망막 질환의 계통인 중심장액성맥락망막병증(Central serous chorioretinopathy)은 후극부에서 자주 발생하는 질 환으로 주로 건강한 남자에게서 경도 및 중등도의 시력저 하를 일으키는 것으로 알려졌다. 황반의 후극부에 국한된 경계가 분명한 장액성 감각신경망막박리 또는 망막색소상 피박리가 나타나는 것을 특징으로 중심암점, 대비감도 저 하 등 광학적 질이 저해되는 증상들이 발생된다. 중심장액성맥락망막병증은 유병기간에 따라 크게 3개월 에서 6개월 이내 호전되는 급성형과 그 외 6개월 이상 경 과한 경우와 잦은 발생 및 호전을 반복하는 만성형으로 나눌 수 있다. 중심장액성맥락망막병증은 3~4개월에 대부 분 자연히 호전되며 시력예후도 비교적 좋은 것으로 알려 졌으나, [3-5] 재발이 잘 되는 질환으로 망막색소상피의 위축 및 증식 등의 망막색소상피의 노화현상과 함께 맥락막 신 생혈관이 발생하는 것으로 알려져 있다. [6, 7]
doi:10.14479/jkoos.2016.21.2.137 fatcat:6drpu2vw4jdvdca56zkrwigpaq